Year 2007 Vol. 15 No 1

REVIEWS

GIDRANOVICH A.V.

LIPID METABOLISM AND BREAST CANCER: INFLUENCE OF THE VITAMIN THERAPY

The lipid metabolism plays a considerable role in the pathogenesis of many diseases. Though the greatest scientific material has been obtained by different investigators, there isn’t the ultimate opinion concerning the degree of lipid metabolism mechanisms involvement in the carcinogenesis including the origin and progression of breast cancer. Breast cancer affects women at pre-menopausal age and women at postmenopausal age, who are characterized by the increased levels of LDL cholesterol and the reduced levels of HDL cholesterol. Some investigators draw parallels between metabolic syndrome in the postmenopausal women (obesity, low glucose tolerance, low serum HDL cholesterol, and high serum triglycerides hypertension) and breast cancer. Development of breast cancer results in the changes of metabolic indexes. In the breast cancer patients, dyslipidemia develops and becomes worse, and it leads to high levels of total cholesterol, triglycerides, LDL cholesterol, low HDL cholesterol. Vitamins directly or indirectly participate in lipid metabolism, resulting in lipid metabolism changes during their consumption. One must take this fact into account in individual rehabilitation program development.

Keywords: breast cancer, lipid metabolism, vitamins.
p. 93 - 102 of the original issue
References
  1. Boyd, N. F. Evidence of association between plasma high-density lipoprotein cholesterol and risk factors for breast cancer / N. F. Boyd, V. McGuire // J. Natl. Cancer Inst. (Bethesda). – 1990. – Vol. 82. – P. 460–468.
  2. Gospodarowicz, D. High-density lipoproteins and the proliferation of human tumor cells maintained on extracellular matrix-coated dishes and exposed to defined medium / D. Gospodarowicz, G. M. Lui, R. Gonzalez // Cancer Res. – 1982. – Vol. 42. – P. 3704–3713.
  3. Ñóêîëèíñêèé, Â. Í. Ïðèìåíåíèå ëåêàðñòâåííûõ ïðåïàðàòîâ àíòèîêñèäàíòíîãî äåéñòâèÿ â ëå÷åíèè áîëüíûõ çëîêà÷åñòâåííûìè îïóõîëÿìè / Â. Í. Ñóêîëèíñêèé [è äð.] // Çäðàâîîõðàíåíèå. – 2004.– ¹5.– C. 59–61.
  4. Cai, C. Overexpression of caveolin-1 increases plasma membrane fluidity and reduces P-glycoprotein function in Hs578T/Dox / C. Cai, H. Zhu, J. Chen // Biochem Biophys Res Commun. – 2004. – Vol. 320, N 3. – P. 868–874.
  5. Serum lipids and tissue DNA content in Egyptian female breast cancer patients / F. A. Abu-Bedair [et al.] // Jpn. J. Clin. Oncol. – 2003. – Vol. 33, N 6. – P. 278–282.
  6. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk / A. S. Furberg [et al.] // J. Natl. Cancer Inst. – 2004. – Vol. 96, N 15. – P. 1152–1160.
  7. Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study / A. S. Furberg [et al.] // Cancer Epidemiol Biomarkers Prev. – 2005. – Vol. 14, N 1. – P. 33–40.
  8. Îñîáåííîñòè äèñëèïèäåìèè ó îíêîëîãè÷åñêèõ áîëüíûõ / Ì. Í. Îñòðîóìîâà [è äð.] // Âîïð. Îíêîëîãèè. – 1986. – ¹1. – Ñ. 34–43
  9. Äèëüìàí, Â. Ì. Ýíäîêðèíîëîãè÷åñêàÿ îíêîëîãèÿ / Â. Ì. Äèëüìàí. – Ë.: Ìåäèöèíà, 1983. – 193 ñ.
  10. A Mutant High-Density Lipoprotein Receptor Inhibits Proliferation of Human Breast Cancer Cells / M. Cao Wen [et al.] // Cancer research. – 2004. – Vol. 64. – P. 1515–1521.
  11. Hussey, S. L. Efficient delivery of streptavidin to mammalian cells: clathrin-mediated endocytosis regulated by a synthetic ligand / S. L. Hussey, B. R. Peterson // J. Am. Chem. Soc. – 2002. – Vol. 124, N 22. – P. 6265-6273.
  12. Moore, R. J. Apolipoprotein E and the risk of breast cancer sin African-American and non-Hispanic white women. A review / R. J. Moore, R. M. Chamberlain, F. R. Khuri // Oncology. – 2004. – Vol. 66, N 2. – P. 79-93.
  13. Morimoto, K. Postoperative changes in serum lipid levels of breast cancer and adjuvant chemotherapy / K. Morimoto, M. Koh // Gan To Kagaku Ryoho. – 2004. – Vol. 31, N10. – P. 1517-1524.
  14. Êàëüÿíîâà, Í. Þ. Âçàèìîñâÿçü àíòèîêèñëèòåëüíîé àêòèâíîñòè è ñîñòàâà ëèïèäîâ êðîâè êàê ïîêàçàòåëü âëèÿíèÿ îïóõîëè íà îðãàíèçì / Í. Þ. Êàëüÿíîâà // Âîïðîñû îíêîëîãèè. – 1989. – Ò. 35, ¹7. – C.796–801.
  15. Ñîñòàâ æèðíûõ êèñëîò ôîñôîëèïèäîâ ìåìáðàí ýðèòðîöèòîâ è ðèñê ðàêà ìîëî÷íîé æåëåçû / Ä. Ã. Çàðèäçå [è äð.] // Âîïðîñû îíêîëîãèè. – 1990. – Ò. 36, ¹ 12. – C. 1442–1448.
  16. Vacca, C. E. Interaction of lipid peroxidation products with DNA. A rewiev / C. E. Vacca, J. Wilheim, M. Harms-Ringdahl // Mutation Res. – 1988. – Vol. 195. – P. 137–149.
  17. Zamaria, N. Alteration of polyunsaturated fatty acid status and metabolism in health and disease / N. Zamaria // Reprod. Nutr. Dev. – 2004. – Vol. 44. – P. 273–282.
  18. Diet in the aetiology of cancer: a review / A. Miller // Eur. J. Cancer. – 1990. – Vol. 30. – P. 207–220.
  19. Willet, W. C. Diet and health: what should we eat? / W. C. Willet // Science. – 1994. – Vol. 264. – P. 532–537.
  20. Rose, D. P. Dietary fatty acids and cancer / D. P. Rose // Am. J. Nutr. – 1997. – Vol. 66. – P. 998–1003.
  21. Byers, T. Issues in the design and interpretation of studies of fatty acids and cancer in humans / T. Byers, K. Gieseker // Am. J. Clin. Nutr. – 1997. – Vol. 66. – P. 1541–1547.
  22. Zhao, H. Long-chain saturated fatty acids induce annexin II translocation to detergent-resistant membranes / H. Zhao, R. W. Hardy // Biochem. J. – 2004. –Vol. 381. – Pt 2. – P. 463-469.
  23. Caroll, K. The role of dietary in breast cancer / K. Caroll // Curr. Opin. Lipidol. – 1997. – ¹ 8. – P. 53–56.
  24. Chemopreventive n-3 Polyunsaturated Fatty Acids Reprogram Genetic Signatures during Colon Cancer Initiation and Progression in the Rat / Laurie A. Davidson [et al.] // Cancer Research. – 2004. – Vol. 64. – P. 6797–6804.
  25. Das, U. N. Reversal of tumor cell drug resistance by essential fatty acids / U. N. Das // Lipids. – 1999. – Vol. 34S. – P. 103.
  26. Polyunsaturated fatty acids and breast cancer / P. Bougnoux [et al.] // Lipids. – 1999. – Vol. 34. – P. 99.
  27. Shureiqi, I. Lipoxygenase Modulation to Reverse Carcinogenesis / I. Shureiqi, S. M. Lippman // Cancer Research. – 2001. – Vol. 61. – P. 6307–6312.
  28. Kleinfeld, A. M. Free fatty acid release from human breast cancer tissue inhibits cytotoxic T-lymphocyte-mediated killing / Alan M. Kleinfeld, Clifford Okada // Journal of Lipid Research. – 2005. – Vol. 46. – P. 1983–1990.
  29. Ñòåðíþê, Þ. Ì. Êîððåêöèÿ ìåòàáîëè÷åñêîé èììóíîäåïðåññèè ó áîëüíûõ ðàêîì ìîëî÷íîé æåëåçû / Þ. Ì. Ñòåðíþê, À. È. Ãíàòûøàê // Òåç. Äîêë. Âñåñîþç. íàó÷. êîíô. «Ñèñòåìíûé ïàòîãåíåòè÷åñêèé ïîäõîä ê ïðîôèëàêòèêå, ðàííåé äèàãíîñòèêå è ëå÷åíèþ ãîðìîíçàâèñèìûõ îïóõîëåé ó æåíùèí». – Íîâãîðîä, 1988. – C.57.
  30. Plasma Folate, Vitamin B6, Vitamin B12, Homocysteine, and Risk of Breast Cancer / Shumin M. Zhang [et al.] // Journal of the National Cancer Institute. – 2003.– Vol. 95, N 5. – P. 373–380.
  31. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer / S. Zhang [et al.] // J. Natl. Cancer. Inst. – 1999. – Vol. 91, N 6. – P. 547-556.
  32. Vitamins A, C and E and the risk of breast cancer: results from a case-control study in Greece / K. Bohlke. [et al.] // Br. J. Cancer. – 1999. – Vol. 79, N 1. – P. 23–29.
  33. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide / A. Costa [et al.] // Cancer Res. – 1994. – Vol 54. – Suppl. 7. – P. 2032–2037.
  34. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer / U. Veronesi [et al.] // J. Natl. Cancer. Inst. – 1999. – Vol. 91, N 21. – P. 1847–1856.
  35. Intravenous vitamin C as a chemotherapy agent: a report on clinical cases / H. D. Riordan [et al.] // P.R. Health Sci. J. – 2004. – Vol. 23, N 2. – P. 115-118.
  36. Dual role of vitamin C on lipid profile and combined application of cyclophosphamide, methotrexate and 5-fluorouracil treatment in fibrosarcoma-bearing rats / G. Muralikrishnan [et al.] // Cancer Lett. – 2001. – Vol. 169, N 2. – P. 115-120.
  37. Oxidant-antioxidant status in relation to survival among breast cancer patients / M. Saintot [et al.] // Int. J. Cancer. – 2002. – Vol. 97, N 5. – P. 574–579.
  38. Serum antioxidant and cholesterol levels in patients with different types of cancer / C. Abiaka [et al.] // J. Clin. Lab. Anal. – 2001. – Vol. 15, N 6. – P. 324–330.
  39. High dietary level of synthetic vitamin E on lipid peroxidation, membrane fatty acid composition and cytotoxicity in breast cancer xenograft and in mouse host tissue / Ivan L Cameron [et al.] // Cancer Cell International. – 2003. – ¹ 3. – P. 3.
  40. Qing Jiang á-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis / Qing Jiang [et al.] // [Ýëåêòðîííûé ðåñóðñ].– Ðåæèì äîñòóïà: www.pnas.org/cgi/doi/10.1073/pnas.0408340102.
  41. Borek, C. Dietary Antioxidants and Human Cancer / Carmia Borek // Integrative Cancer Therapies. – 2004. – Vol. 3, N 4. – P. 333-341
  42. Ïîäàâëåíèå ñóïåðýêñïðåññèè ïðîòîîíêîãåíà îðíèòèíäåêàðáîêñèëàçû â àäåíîìàòîçíûõ ïîëèïàõ òîëñòîé êèøêè ïðè íàçíà÷åíèè áîëüíûì âûñîêèõ äîç ôîëèåâîé êèñëîòû / Â. À. Äðàóäèí-Êðûëåíêî // Ñîâðåìåííàÿ îíêîëîãèÿ. – 2004. – Ò.6, ¹3.
  43. Lu, Y. Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects / Y. Lu, P. S. Low // Journal of Controlled Release. – 2003. – Vol. 91. – P. 18– 29.
  44. Draser, H. S. Environmental factors and cancer of the colon and breast / H. S. Draser, D. Irving // Br. J. Cancer. – 1973. – Vol. 27. – P. 167–172.
  45. Zhang, L. Proliferative activity of murine mammary epithelium as affected by dietary fat and calcium / L. Zhang, R. P. Bird, W. R. Bruce // Cancer Res. – 1987. – Vol. 47. – P. 4905–4908.
  46. Welsch, C.W. Enhancement of mammary tumorigenesis by dietary fat: Review of potential mechanisms / C. W. Welsch // Am. J. Clin. Nutr. – 1987. – Vol. 45. – P. 192–202.
  47. Vitamin D adequacy: A possible relationship to breast cancer./ U. Veronesi [et al.]; ed. E. K. Weisburger // “Conference on Diet and Cancer: Diet and Breast Cancer,” 4th Conference, Washington, DC, 1993. – New York: Plenum. – 1994. – P. 109–114.
  48. Mammary ductal epithelial cell hyperproliferation and hyperplasia induced by four components of a Western-style diet / M. Khan [et al.] // Carcinogenesis. – 1994 .– Vol. 15. – P. 2645–2648.
  49. Model of mouse mammary gland hyperproliferation and hyperplasia induced by a Western-style diet / L. X. Xue [et al.] // Nutr. Cancer. – 1996. – Vol. 26. – P. 281–287.
  50. Influence of dietary calcium and vitamin D on diet-induced epithelial cell hyperproliferation in mice / L Xue.[et al.] // J. Natl. Can. Inst. – 1999. – Vol. 91. – P. 176–181.
  51. Inhibition of Western diet induced hyperproliferation and hyperplasia in mouse colon by two sources of calcium / F. Richter [et al.] // Carcinogenesis. – 1995. – Vol. 16. – P. 2685–2689.
  52. 1,24(S)-dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors / G. M. Zinser [et al.] // Anticancer Res. – 2005. – Vol. 25. – P. 235-241.
  53. Autocrine metabolism of vitamin D in normal and malignant breast tissue / K. Townsend [et al.] // Clin. Cancer Res. – 2005. – Vol. 11, N 9. – P. 3579–3586.
  54. Duncan, R. E. Dietary factors and the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase: implications for breast cancer and development / R. E. Duncan, A. El-Sohemy, M. C. Archer // Mol. Nutr. Food. Res. – 2005. – ol. 49, N 2. – P. 93–100.
  55. Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity / R. E. Duncan[et al.] // Biochem. Pharmacol. – 2004. – Vol. 68, N 9. – P. 1739–1747.
  56. Effects of lovastatin on cell cycle distribution in MCF-7 cells transfected with BRCA1 / Y. Q. Luo [et al.] // Ai Zheng. – 2004. – Vol. 23, N 8. – P. 924-928.
  57. Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project / M. A. Pfeffer [et al.] // Circula-tion. – 2002. – Vol. 105, N 20. – 2341–2346.
Contacts | ©Vitebsk State Medical University, 2007-2023